For patients obtaining other opioid analgesics and switching to this drug or for the extended-launch formulations of the drug, it can be safer to undervalue a affected individual's 24-hour oral need and provide rescue medication than overestimate and manage an adverse reaction; There is certainly substantial inter-client variation while in the rela